Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2022

Open Access 01-12-2022 | Breast Cancer | Study protocol

AMAZONE: prevention of persistent pain after breast cancer treatment by online cognitive behavioral therapy—study protocol of a randomized controlled multicenter trial

Authors: Anne Lukas, Maurice Theunissen, Dianne de Korte-de Boer, Sander van Kuijk, Lotte Van Noyen, Walter Magerl, Werner Mess, Wolfgang Buhre, Madelon Peters

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

Surviving breast cancer does not necessarily mean complete recovery to a premorbid state of health. Among the multiple psychological and somatic symptoms that reduce the quality of life of breast cancer survivors, persistent pain after breast cancer treatment (PPBCT) with a prevalence of 15–65% is probably the most invalidating. Once chronic, PPBCT is difficult to treat and requires an individualized multidisciplinary approach. In the past decades, several somatic and psychological risk factors for PPBCT have been identified. Studies aiming to prevent PPBCT by reducing perioperative pain intensity have not yet shown a significant reduction of PPBCT prevalence. Only few studies have been performed to modify psychological distress around breast cancer surgery. The AMAZONE study aims to investigate the effect of online cognitive behavioral therapy (e-CBT) on the prevalence of PPBCT.

Methods

The AMAZONE study is a multicenter randomized controlled trial, with an additional control arm. Patients (n=138) scheduled for unilateral breast cancer surgery scoring high for surgical or cancer-related fears, general anxiety or pain catastrophizing are randomized to receive either five sessions of e-CBT or online education consisting of information about surgery and a healthy lifestyle (EDU). The first session is scheduled before surgery. In addition to the online sessions, patients have three online appointments with a psychotherapist. Patients with low anxiety or catastrophizing scores (n=322) receive treatment as usual (TAU, additional control arm).
Primary endpoint is PPBCT prevalence 6 months after surgery.
Secondary endpoints are PPBCT intensity, the intensity of acute postoperative pain during the first week after surgery, cessation of postoperative opioid use, PPBCT prevalence at 12 months, pain interference, the sensitivity of the nociceptive and non-nociceptive somatosensory system as measured by quantitative sensory testing (QST), the efficiency of endogenous pain modulation assessed by conditioned pain modulation (CPM) and quality of life, anxiety, depression, catastrophizing, and fear of recurrence until 12 months post-surgery.

Discussion

With perioperative e-CBT targeting preoperative anxiety and pain catastrophizing, we expect to reduce the prevalence and intensity of PPBCT. By means of QST and CPM, we aim to unravel underlying pathophysiological mechanisms. The online application facilitates accessibility and feasibility in a for breast cancer patients emotionally and physically burdened time period.

Trial registration

NTR NL9132, registered December 16 2020.
Literature
1.
Tait RC, Zoberi K, Ferguson M, Levenhagen K, Luebert RA, Rowland K, et al. Persistent post-mastectomy pain: risk factors and current approaches to treatment. J Pain. 2018;19(12):1367–83.PubMedPubMedCentralCrossRef
2.
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–25.PubMedCrossRef
3.
Bell RJ, Robinson PJ, Nazeem F, Panjari M, Fradkin P, Schwarz M, et al. Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv. 2014;8(1):1–8.PubMedCrossRef
4.
Lauridsen MC, Overgaard M, Overgaard J, Hessov IB, Cristiansen P. Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol. 2008;47(4):569–75.PubMedCrossRef
5.
McNeely ML, Binkley JM, Pusic AL, Campbell KL, Gabram S, Soballe PW. A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues. Cancer. 2012;118(8 Suppl):2226–36.PubMedCrossRef
6.
Stubblefield MD, McNeely ML, Alfano CM, Mayer DK. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Cancer. 2012;118(8 Suppl):2250–60.PubMedCrossRef
7.
Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol. 2016;34(6):611–35.PubMedCrossRef
8.
Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 1996;64(2):293–302.CrossRef
9.
Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain. 2002;6(1):17–24.PubMedCrossRef
10.
Watson CP, Evans RJ. The postmastectomy pain syndrome and topical capsaicin: a randomized trial. Pain. 1992;51(3):375–9.PubMedCrossRef
11.
Hetta DF, Mohamed SAB, Mohamed KH, Mahmoud TAE, Eltyb HA. Pulsed radiofrequency on thoracic dorsal root ganglion versus thoracic paravertebral nerve for chronic postmastectomy pain, a randomized trial: 6-month results. Pain Physician. 2020;23(1):23–35.PubMed
12.
Abbas DN, Reyad RM. Thermal versus super voltage pulsed radiofrequency of stellate ganglion in post-mastectomy neuropathic pain syndrome: a prospective randomized trial. Pain Physician. 2018;21(4):351–62.PubMedCrossRef
13.
Hetta DF, Mohamed AA, Hetta HF, Abd El-Hakeem EE, Boshra MM, El-Barody MM, et al. Radiofrequency thoracic sympathectomy for sympathetically maintained chronic post-mastectomy pain, a preliminary report: 6-month results. Pain Pract. 2021;21(1):54–63.PubMedCrossRef
14.
Zocca JA, Chen GH, Puttanniah VG, Hung JC, Gulati A. Ultrasound-guided serratus plane block for treatment of postmastectomy pain syndromes in breast cancer patients: a case series. Pain Pract. 2017;17(1):141–6.PubMedCrossRef
15.
Theunissen M, Peters ML, Bruce J, Gramke HF, Marcus MA. Preoperative anxiety and catastrophizing: a systematic review and meta-analysis of the association with chronic postsurgical pain. Clin J Pain. 2012;28(9):819–41.PubMedCrossRef
16.
Bruce J, Thornton AJ, Powell R, Johnston M, Wells M, Heys SD, et al. Psychological, surgical, and sociodemographic predictors of pain outcomes after breast cancer surgery: a population-based cohort study. Pain. 2014;155(2):232–43.PubMedCrossRef
17.
Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain. 2015;156(12):2413–22.PubMedCrossRef
18.
Ruscheweyh R, Viehoff A, Tio J, Pogatzki-Zahn EM. Psychophysical and psychological predictors of acute pain after breast surgery differ in patients with and without pre-existing chronic pain. Pain. 2017;158(6):1030–8.PubMedCrossRef
19.
Fernandez-Lao C, Cantarero-Villanueva I, Fernandez-de-las-Penas C, Del-Moral-Avila R, Menjon-Beltran S, Arroyo-Morales M. Widespread mechanical pain hypersensitivity as a sign of central sensitization after breast cancer surgery: comparison between mastectomy and lumpectomy. Pain Med. 2010;12(1):72–8.PubMedCrossRef
20.
Gottrup H, Andersen J, Arendt-Nielsen L, Jensen TS. Psychophysical examination in patients with post-mastectomy pain. Pain. 2000;87(3):275–84.PubMedCrossRef
21.
Andersen KG, Duriaud HM, Aasvang EK, Kehlet H. Association between sensory dysfunction and pain 1 week after breast cancer surgery: a psychophysical study. Acta Anaesthesiol Scand. 2016;60(2):259–69.PubMedCrossRef
22.
23.
Edwards RR, Mensing G, Cahalan C, Greenbaum S, Narang S, Belfer I, et al. Alteration in pain modulation in women with persistent pain after lumpectomy: influence of catastrophizing. J Pain Symp Manage. 2013;46(1):30–42.CrossRef
24.
Schreiber KL, Martel MO, Shnol H, Shaffer JR, Greco C, Viray N, et al. Persistent pain in postmastectomy patients: comparison of psychophysical, medical, surgical, and psychosocial characteristics between patients with and without pain. Pain. 2013;154(5):660–8.PubMedCrossRef
25.
Yarnitsky D. Role of endogenous pain modulation in chronic pain mechanisms and treatment. Pain. 2015;156(Suppl 1):S24–31.PubMedCrossRef
26.
Petersen KK, Vaegter HB, Stubhaug A, Wolff A, Scammell BE, Arendt-Nielsen L, et al. The predictive value of quantitative sensory testing: a systematic review on chronic postoperative pain and the analgesic effect of pharmacological therapies in patients with chronic pain. Pain. 2021;162(1):31–44.PubMedCrossRef
27.
28.
Carley ME, Chaparro LE, Choinière M, Kehlet H, Moore RA, Van Den Kerkhof E, et al. Pharmacotherapy for the prevention of chronic pain after surgery in adults: an updated systematic review and meta-analysis. Anesthesiology. 2021;135(2):304–25.PubMedCrossRef
29.
Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain. 2010;26(5):381–5.PubMedCrossRef
30.
Karmakar MK, Samy W, Li JW, Lee A, Chan WC, Chen PP, et al. Thoracic paravertebral block and its effects on chronic pain and health-related quality of life after modified radical mastectomy. Region Anesth Pain Med. 2014;39(4):289–98.CrossRef
31.
Aufforth R, Jain J, Morreale J, Baumgarten R, Falk J, Wesen C. Paravertebral blocks in breast cancer surgery: is there a difference in postoperative pain, nausea, and vomiting? Ann Surg Oncol. 2012;19(2):548–52.PubMedCrossRef
32.
Ilfeld BM, Madison SJ, Suresh PJ, Sandhu NS, Kormylo NJ, Malhotra N, et al. Treatment of postmastectomy pain with ambulatory continuous paravertebral nerve blocks: a randomized, triple-masked, placebo-controlled study. Region Anesth Pain Med. 2014;39(2):89–96.CrossRef
33.
Heesen M, Klimek M, Rossaint R, Imberger G, Straube S. Paravertebral block and persistent postoperative pain after breast surgery: meta-analysis and trial sequential analysis. Anaesthesia. 2016;71(12):1471–81.PubMedCrossRef
34.
Hussain N, Shastri U, McCartney CJL, Gilron I, Fillingim RB, Clarke H, et al. Should thoracic paravertebral blocks be used to prevent chronic postsurgical pain after breast cancer surgery? A systematic analysis of evidence in light of IMMPACT recommendations. Pain. 2018;159(10):1955–71.PubMedCrossRef
35.
Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A, et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet. 2019;394(10211):1807–15.PubMedCrossRef
36.
Albi-Feldzer A, Dureau S, Ghimouz A, Raft J, Soubirou JL, Gayraud G, et al. Preoperative paravertebral block and chronic pain after breast cancer surgery: a double-blind randomized trial. Anesthesiology. 2021;135(6):1091–103.PubMedCrossRef
37.
Giusti EM, Lacerenza M, Manzoni GM, Castelnuovo G. Psychological and psychosocial predictors of chronic postsurgical pain: a systematic review and meta-analysis. Pain. 2021;162(1):10–30.PubMedCrossRef
38.
Jackson T, Tian P, Wang Y, Iezzi T, Xie W. Toward identifying moderators of associations between presurgery emotional distress and postoperative pain outcomes: a meta-analysis of longitudinal studies. J Pain. 2016;17(8):874–88.PubMedCrossRef
39.
Kaunisto MA, Jokela R, Tallgren M, Kambur O, Tikkanen E, Tasmuth T, et al. Pain in 1,000 women treated for breast cancer: a prospective study of pain sensitivity and postoperative pain. Anesthesiology. 2013;119(6):1410–21.PubMedCrossRef
40.
Starr CJ, Houle TT, Coghill RC. Psychological and sensory predictors of experimental thermal pain: a multifactorial model. J Pain. 2010;11(12):1394–402.PubMedPubMedCentralCrossRef
41.
Thompson T, Keogh E, French CC, Davis R. Anxiety sensitivity and pain: generalisability across noxious stimuli. Pain. 2008;134(1-2):187–96.PubMedCrossRef
42.
Traxler J, Hanssen MM, Lautenbacher S, Ottawa F, Peters ML. General versus pain-specific cognitions: pain catastrophizing but not optimism influences conditioned pain modulation. Eur J Pain. 2019;23(1):150–9.PubMedCrossRef
43.
44.
Chen T, Taniguchi W, Chen QY, Tozaki-Saitoh H, Song Q, Liu RH, et al. Top-down descending facilitation of spinal sensory excitatory transmission from the anterior cingulate cortex. Nat Commun. 2018;9(1):1886.PubMedPubMedCentralCrossRef
45.
Clarke H, Poon M, Weinrib A, Katznelson R, Wentlandt K, Katz J. Preventive analgesia and novel strategies for the prevention of chronic post-surgical pain. Drugs. 2015;75(4):339–51.PubMedCrossRef
46.
Burns JW, Bruehl S, France CR, Schuster E, Orlowska D, Buvanendran A, et al. Psychosocial factors predict opioid analgesia through endogenous opioid function. Pain. 2017;158(3):391–9.PubMedCrossRef
47.
Nadinda PG, van Ryckeghem DML, Peters ML. Can perioperative psychological interventions decrease the risk of postsurgical pain and disability? A systematic review and meta-analysis of randomized controlled trials. Pain. 2022;163(7):1254–73.PubMedCrossRef
48.
Hadlandsmyth K, Conrad M, Steffensmeier KS, Van Tiem J, Obrecht A, Cullen JJ, et al. Enhancing the biopsychosocial approach to perioperative care: a pilot randomized trial of the perioperative pain self-management (PePS) intervention. Ann Surg. 2022;275(1):e8–e14.PubMedCrossRef
49.
Darnall BD, Ziadni MS, Krishnamurthy P, Mackey IG, Heathcote L, Taub CI, et al. “My Surgical success” : effect of a digital behavioral pain medicine intervention on time to opioid cessation after breast cancer surgery - a pilot randomized controlled clinical trial. Pain Med. 2019;20(11):2228–37.PubMedPubMedCentralCrossRef
50.
Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E. Guided Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatr. 2014;13(3):288–95.CrossRef
51.
Post KE, Flanagan J. Web based survivorship interventions for women with breast cancer: an integrative review. Eur J Oncol Nurs. 2016;25:90–9.PubMedCrossRef
52.
Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiat Scand. 1983;67:361–70.PubMedCrossRef
53.
Vickberg SM. The Concerns About Recurrence Scale (CARS): a systematic measure of women's fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25(1):16–24.PubMedCrossRef
54.
Sullivan M, Bishop S, Pivik J. The Pain Catastrophizing Scale: developement and validation. Psychol Assesment. 1995;7:524–32.CrossRef
55.
Riddle DL, Keefe FJ, Ang DC, Slover J, Jensen MP, Bair MJ, et al. Pain coping skills training for patients who catastrophize about pain prior to knee arthroplasty: a multisite randomized clinical trial. J Bone Joint Surg Am. 2019;101(3):218–27.PubMedCrossRef
56.
Riddle DL, Keefe FJ, Nay WT, McKee D, Attarian DE, Jensen MP. Pain coping skills training for patients with elevated pain catastrophizing who are scheduled for knee arthroplasty: a quasi-experimental study. Arch Phys Med Rehabil. 2011;92(6):859–65.PubMedPubMedCentralCrossRef
57.
Darnall BD, Sturgeon JA, Kao MC, Hah JM, Mackey SC. From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing. J Pain Res. 2014;7:219–26.PubMedPubMedCentralCrossRef
58.
van de Wal MA, Gielissen MF, Servaes P, Knoop H, Speckens AE, Prins JB. Study protocol of the SWORD-study: a randomised controlled trial comparing combined online and face-to-face cognitive behaviour therapy versus treatment as usual in managing fear of cancer recurrence. BMC Psychology. 2015;3(1):12.PubMedPubMedCentralCrossRef
59.
van Seventer R, Vos C, Giezeman M, W. JM, Arnould B, Regnault A, et al. Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain. Pain Pract. 2013;13(5):390–8.PubMedCrossRef
60.
Cleeland C. Measurement of pain by subjective report. In: Chapman C, Loeser J, editors. Advances in pain research and therapy. 12th ed. New York: Raven Press; 1989. p. 391–403.
61.
Rolke R, Baron R, Maier C, Tolle TR, Treede RD, Beyer A, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123(3):231–43.PubMedCrossRef
62.
Yarnitsky D, Arendt-Nielsen L, Bouhassira D, Edwards RR, Fillingim RB, Granot M, et al. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain. 2010;14(4):339.PubMedCrossRef
63.
Hudak P, Amadio P, Bombardier C. Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG). Am J Ind Med. 1996;29(6):602–8.PubMedCrossRef
64.
65.
66.
Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–68.PubMedCrossRef
67.
Theunissen M, Peters M, Schouten E, Fiddelers A, Willemsen M, Pinto P, et al. Validation of the surgical fear questionnaire in adult patients waiting for elective surgery. PLoS One. 2014;9(6):e100225.PubMedPubMedCentralCrossRef
68.
van den Beuken-van Everdingen MH, Peters ML, de Rijke JM, Schouten HC, van Kleef M, Patijn J. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study. Psychooncology. 2008;17(11):1137–45.PubMedCrossRef
69.
VanDenKerkhof EG, Peters ML, Bruce J. Chronic pain after surgery: time for standardization? A framework to establish core risk factor and outcome domains for epidemiological studies. Clin J Pain. 2013;29(1):2–8.PubMedCrossRef
70.
Pereira S, Fontes F, Sonin T, Dias T, Fragoso M, Castro-Lopes J, et al. Neuropathic pain after breast cancer treatment: characterization and risk factors. J Pain Symp Manage. 2017;54(6):877–88.CrossRef
71.
Burns J, Moric M. Psychosocial factors appear to predict postoperative pain: interesting, but how can such information be used to reduce risk? Techniques Region Anesth Pain Manage. 2011;15:90–9.CrossRef
Metadata
Title
AMAZONE: prevention of persistent pain after breast cancer treatment by online cognitive behavioral therapy—study protocol of a randomized controlled multicenter trial
Authors
Anne Lukas
Maurice Theunissen
Dianne de Korte-de Boer
Sander van Kuijk
Lotte Van Noyen
Walter Magerl
Werner Mess
Wolfgang Buhre
Madelon Peters
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06549-6

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue

Commentary

Pragmatic trials can address diagnostic controversies: recent lessons from gestational diabetes

Study protocol

Effect of different feeding methods on gastrointestinal function in critical patients (DFM-GFC): study protocol for a randomized controlled trial

Study protocol

Guided meditation for vision acuity training on adolescent myopia: study protocol for an open-label, prospective, multicenter, randomized controlled trial

Research

Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer

Study protocol

Dulce Digital-Me: protocol for a randomized controlled trial of an adaptive mHealth intervention for underserved Hispanics with diabetes

Study protocol

STRONG for Surgery & Strong for Life — against all odds: intensive prehabilitation including smoking, nutrition, alcohol and physical activity for risk reduction in cancer surgery — a protocol for an RCT with nested interview study (STRONG-Cancer)